We make minority investments – directly from the JPMorganChase balance sheet – and typically seek late-stage ventures with demonstrable market fit and growth potential. Morgan Health has a double bottom line – aiming to generate financial returns while also driving innovation within the U.S. health care system.
Beyond our capital commitment, we offer strategic support to fuel the long-term growth and development of our portfolio companies. This includes close engagement with Boards of Directors and executive leadership teams on strategy, product development, operational improvement, business development and strategic partnerships.
Our investments are focused on scaling innovations that meet the needs of employers and patients alike.
Advancing cancer care for employees and employers.
Administers Individual Coverage Health Reimbursement Arrangements.
Provides data, analytics and technology to deliver an integrated view of health care quality and cost.
Comprehensive care for neurodivergent children through an integrated, physician-led team.
Digital health and benefits analytics – using AI-powered technology and expert support.
Leader in advanced primary care and patient-centric health care.
Health plans that emphasize primary care, designed for self-insured employers.
Physician-led analytics company that provides actionable data on provider quality to relevant stakeholders.
A fertility clinic network and family building benefits provider for employers.
A technology-powered company focused on helping patients manage their conditions from home.
Merative is thrilled to work with Morgan Health, a forward-thinking investor with deep expertise in the employer health care space. Their reach, credibility and understanding of market needs make them an ideal collaborator for our Truven data and analytics portfolio.